<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="167598">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00915681</url>
  </required_header>
  <id_info>
    <org_study_id>SB16A1.07</org_study_id>
    <nct_id>NCT00915681</nct_id>
  </id_info>
  <brief_title>Intravenous Milk Thistle (Silibinin-Legalon) for Hepatic Failure Induced by Amatoxin/Amanita Mushroom Poisoning</brief_title>
  <official_title>Prevention and Treatment of Amatoxin Induced Hepatic Failure With Intravenous Silibinin ( Legalon速 SIL): An Open Multicenter Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Madaus Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mylan Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Madaus Inc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Legalon速 SIL will be administered to patients with amatoxin poisoning diagnosed by history,
      gastrointestinal symptoms, elevated liver enzymes, and/or diagnostic assay (should one
      become available). Patients may or may not also demonstrate abnormalities in bilirubin
      and/or creatinine. Treatment consists of a 5 mg/kg loading dose followed by 20 mg/kg/day via
      continuous infusion. The treating physician is expected to administer supportive therapy of
      his/her choosing but consistent with best practices. Legalon速 SIL will be stopped when
      coagulopathy is no longer present, and when liver function tests have returned significantly
      towards the normal range. Patients will be followed 7-14 days after the end of Legalon速 SIL
      therapy with follow up lab studies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with suspected amatoxin poisoning are reviewed for enrollment in the study by
      contacting the Legalon SIL study hotline (866) 520-4412.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>percentage of patients survived without liver transplantation</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Amatoxin Poisoning</condition>
  <condition>Amanita Poisoning</condition>
  <condition>Mushroom Poisoning</condition>
  <condition>Liver Failure</condition>
  <arm_group>
    <arm_group_label>Legalon SIL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Silibinin: loading dose of one hour infusion of 5 mg/kg, followed by 20 mg/kg/day infused continuously via pump</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Silibinin</intervention_name>
    <description>20 mg/kg/day IV</description>
    <arm_group_label>Legalon SIL</arm_group_label>
    <other_name>Legalon SIL</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  History of eating foraged mushrooms

          -  Gastrointestinal symptoms suggestive of amatoxin poisoning (cramping abdominal pain,
             nausea, vomiting, and / or watery diarrhea) within 48 hrs of mushroom ingestion

          -  Liver function tests suggestive of amatoxin poisoning: AST or ALT above the upper
             limit of normal within 48 hrs after mushroom ingestion

          -  Gender: male or female

          -  Age: &gt; 2 yr
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Todd Mitchell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dominican Santa Cruz Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Todd Mitchell, MD</last_name>
    <phone>831-479-7916</phone>
    <email>tmitchmd@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gail L Tribble, BSN</last_name>
    <phone>412-651-9530</phone>
    <email>gail.tribble@mylan.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dominican Santa Cruz Hospital</name>
      <address>
        <city>Santa Cruz</city>
        <state>California</state>
        <zip>95065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Todd Mitchell, MD</last_name>
      <phone>831-479-7916</phone>
      <email>tmitchMD@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Todd Mitchell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Recruitment Hot Line for the United States</name>
      <address>
        <city>Somerset</city>
        <state>New Jersey</state>
        <zip>08873</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Todd Mitchell, MD</last_name>
      <phone>866-520-4412</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <lastchanged_date>April 3, 2017</lastchanged_date>
  <firstreceived_date>June 4, 2009</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>amatoxin</keyword>
  <keyword>amanita</keyword>
  <keyword>mushroom poisoning</keyword>
  <keyword>hepatic failure</keyword>
  <keyword>milk thistle</keyword>
  <keyword>Silibinin</keyword>
  <keyword>Legalon</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Liver Failure</mesh_term>
    <mesh_term>Poisoning</mesh_term>
    <mesh_term>Mushroom Poisoning</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Silybin</mesh_term>
    <mesh_term>Silymarin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
